Jack Heptinstall

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Peter B. Gilbert, Yunda Huang, Allan C. deCamp et al. · Nature Medicine · 2022 · 126 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

Zoe Moodie, One Dintwe, Sheetal Sawant et al. · The Journal of Infectious Diseases · 2022 · 50 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and Immunogenicity of Ad26-Vectored HIV Vaccine With Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-Uninfected Adults: A Phase 1/2a Study

Daniel J Stieh, Dan H. Barouch, Christy Comeaux et al. · The Journal of Infectious Diseases · 2022 · 36 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein

Mina C. Hosseinipour, Craig Innes, Sarita Naidoo et al. · Clinical Infectious Diseases · 2020 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

Kelly E. Seaton, Yunda Huang, Shelly Karuna et al. · EBioMedicine · 2023 · 33 citations · Full text

Pharmacy, Immunology, Pharmacokinetics +11